Provider Review
Ready to check eligibility?
Disclosure: If you purchase through this link, we may earn a commission at no extra cost to you. This does not influence our assessment.
Hims is the men's telehealth brand of Hims & Hers Health, Inc., a publicly traded company (NYSE: HIMS) best known for ED and hair-loss treatment before expanding into low testosterone. Its low-T lineup is oral-and-topical only right now: enclomiphene (which stimulates your own testosterone production rather than replacing it directly), a partnered branded oral testosterone (Kyzatrex), and topical cream/gel options — with injectable testosterone announced but not yet available as of this review.
That's a meaningful difference from injection-based competitors and worth knowing before you sign up if injections are specifically what you're after. Pricing starts low ($39–99/month depending on formulation), and the scale of a large public company brings broad clinician availability, though it also means less of the "boutique concierge" feel some competitors emphasize. We couldn't find one clean, TRT-specific third-party review score — general Hims ratings on aggregator sites vary by category and cover the whole platform, not this vertical specifically.
As published on hims.com, verified September 21, 2026.
| Item | Cost |
|---|---|
| Enclomiphene (10-month prepaid plan) | From $99/month |
| Topical testosterone cream/gel | From $39/month |
| Oral testosterone (Kyzatrex, w/ Marius Pharmaceuticals) | Varies by plan |
| Injectable testosterone | ⚠️ Not currently available (announced for 2026) |
| Component | Cost |
|---|---|
| 10-month prepaid plan at $99/mo | $990 |
| Remaining ~2 months, estimated at same rate | ~$198 |
| Year 1 total (approximate) | ~$1,188 |
How billing works: Hims runs on a cancel-anytime subscription. Cancel through the Subscriptions tab in your account or the app; canceling ends your active medication plan and access to care through the platform immediately.
Not currently. As of this review, Hims offers oral (enclomiphene, Kyzatrex) and topical options only; injectable testosterone has been announced for 2026 but isn't available yet.
From $39/month for topical options, or $99/month for enclomiphene on a 10-month prepaid plan. Oral Kyzatrex pricing varies by plan.
No, not for most treatments, though HSA/FSA cards are accepted.
Yes, cancel through your account's Subscriptions tab. Canceling ends your active medication plan and access to care through the platform immediately.
Broadly, but not all 50 states, and some states require a video visit with a provider rather than fully async care.
Hims is a product line of Hims & Hers Health, Inc., a publicly traded telehealth company (NYSE: HIMS).
No — enclomiphene stimulates your body to produce more of its own testosterone, rather than replacing it directly like injectable or topical testosterone does. It works differently and isn't the right fit for everyone.
Medical disclaimer: This content is for informational purposes only and is not medical advice. Testosterone replacement therapy requires a prescription and physician supervision. Always consult a qualified healthcare professional before starting treatment.